SecBot SecBot
8-K ·Filed Jun 18, 2026

SNOA

Sonoma Pharmaceuticals, Inc.
BEARISH
Impact 6/10
Horizonweeks Processed4mo ago SEC0001683168-26-004975
8-K context-dependent: Items 8.01
Actionable Insight ▼ Bearish

The filing signals continued equity dilution via an ATM facility that has already been tapped. With a $2M market cap, the $3.64M potential offering represents massive dilution risk. Monitor future 8-Ks for actual share sales under the facility, which will further depress SNOA.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
SNOA ▲ +10.34% at T+60d
SHORT call ✗ call lost -10.34% · α vs SPY -8.60% · entry $1.16 → $1.28
Entry = T+0 close
Jun 18, 2026
via day close
T+1d
-1.72%
call +1.72% · α +0.27%
$1.14
settled 4mo ago
T+5d
-3.45%
call +3.45% · α +1.38%
$1.12
settled 4mo ago
T+20d
+4.31%
call -4.31% · α -4.46%
$1.21
settled 3mo ago
T+60d
+10.34%
call -10.34% · α -8.60%
$1.28
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Sonoma Pharmaceuticals filed an 8-K to update the maximum offering amount under its existing at-the-market (ATM) equity sales agreement with Ladenburg Thalmann to $3,641,703, reflecting a $1,571,240 increase from the prior $2,070,463 cap. The company has already sold 173,073 shares for $574,633 under the facility since September 2025.

Key Facts

  • Sonoma increased its ATM offering capacity from $2,070,463 to $3,641,703, a $1,571,240 increase
  • Since September 2025, the company sold 173,073 shares for $574,633 under the ATM facility
  • The company has a $2M market cap, making the new $3.64M offering capacity ~182% of current market cap
  • The ATM is an ongoing equity-dilution facility with no stated use of proceeds

Financial Impact

The company has already raised $574,633 in equity since September 2025 and now has capacity to sell up to $3,641,703 more (approximately 182% of current $2M market cap).

dilutionequity

Risk Factors

  • Massive potential dilution — $3.64M offering capacity vs $2M market cap
  • No stated use of proceeds, suggesting cash-burn funding
  • Continued equity sales will pressure the stock price

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001683168-26-004975
Document: sonoma_ex0501.htm0001683168-26-004975
Document: 0001683168-26-004975-index-headers.html0001683168-26-004975
Document: 0001683168-26-004975-index.html0001683168-26-004975
Document: 0001683168-26-004975.txt0001683168-26-004975
6 reports for SNOA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SNOA — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$1.22 $1.16▼ −4.92%▼ −4.49%$1.12 (−8.20%)
Jun 18, 2026
18w ago
8-K
BEARISH ★ 6/10
$1.16 $1.14▲ +1.72%▲ +0.27%$1.12 (+3.45%)
Jun 18, 2026
18w ago
424B5
BEARISH ★ 6/10
$1.16 $1.14▲ +1.72%▲ +0.27%$1.12 (+3.45%)
Apr 27, 2026
26w ago
424B4
BEARISH ★ 6/10
$1.11 $1.04▲ +6.31%▲ +5.82%$1.12 (−0.90%)
Apr 17, 2026
27w ago
S-1
NEUTRAL ★ 5/10
$2.65 $2.25▼ −15.09%▼ −14.44%$1.12 (−57.74%)
Apr 9, 2026
28w ago
8-K
NEUTRAL ★ 4/10
$2.41 $2.28▼ −5.39%▼ −5.33%$1.12 (−53.53%)
Showing 6 of 6

US Market Status

Market Closed — Opens in 5h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026